Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» That big new hyperparathyroidism drug from Amgen? The FDA rejected it
That big new hyperparathyroidism drug from Amgen? The FDA rejected it
That big new hyperparathyroidism drug from Amgen? The FDA rejected it
Submitted by
admin
on August 25, 2016 - 9:38am
Source:
Endpoints
News Tags:
secondary hyperparathyroidism
Amgen
FDA
AMG416
Headline:
That big new hyperparathyroidism drug from Amgen? The FDA rejected it
Do Not Allow Advertisers to Use My Personal information
